ghk-cu subcutaneous injection clinical trial dose 7% ACCELERANT GHK-Cu Dosage: A Doctor's Guide
Description
Limited experimental evidence from animal and tissue cultures suggest that IGF-I complexed with IGFBP-1 and -2 may leave the circulation, although the extent and importance is unclear (Bar 1990)
What did not change: the bioavailability question
Brain histology
Red Blood Cell Formation
